Blue dye offers hope for patients with untreatable skin cancer
NCT ID NCT07311070
Summary
This study is testing whether a blue dye called methylene blue, applied directly to the skin, can shrink tumors and help wounds heal in people with advanced basal cell carcinoma who cannot have surgery or radiation. Researchers will apply the treatment every two days for a month and monitor patients for six months to see if it's safe and effective. The goal is to provide a new, non-invasive option for patients with limited treatment choices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INOPERABLE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mashhad University of Medical Sciences
Mashhad, Khorasan Razavi, Iran
Conditions
Explore the condition pages connected to this study.